The company was unable to comply with requirements including having a minimum bid price of at least $1 per share and stockholder equity of at least $2.5 million.
The company aims through the effort to develop better understandings of Kaiser's ovarian cancer care pathways and where its tests might be able to offer improvements.
The funds will support development of a test for detection of multiple tick-borne diseases that Ceres plans to take through the US Food and Drug Administration.
Researchers have discovered four new proteins that contribute to disease progression in Huntington's Disease.
The study used a modified version of Myriad RBM's DiscoveryMAP immunoassay panel to measure levels of 237 proteins in blood samples from 8,401 patients.
In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.
A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.
As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.
The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.